Iowa Board of Pharmacy
400 SW 8th St
Ste E
Des Moines, IA 50309
United States
The January Board meeting has been condensed into a one day meeting and will be held Tuesday, January 11, 2022.
Meeting Location: The meeting will be held via Zoom and in-person at the Board of Pharmacy office. To access the meeting, see details below:
Join Zoom Meeting:
https://zoom.us/join
Meeting ID: 830 1326 9484
Passcode: n5v4TE
One tap mobile
312-626-6799, 83013269484#,*378029# US (Chicago)
Face masks are recommended for all in-person attendees and required for those who are unvaccinated
If you have a fever, cough, shortness of breath or have been exposed to someone with COVID-19 please attend remotely via Zoom.
9:00 a.m. Call to Order
Call to Order and Announcements
Public Comment Period—anyone who has submitted material for the agenda will be given an opportunity to address the Board during the particular agenda item. A member of the public wishing to address the Board regarding a particular agenda item should raise a hand during that agenda item to be recognized. During the initial public comment period, members of the public will have the opportunity to address the Board regarding any items not on the agenda, or any agenda item if the person is unable to be present for the discussion of the particular agenda item. Acknowledgment and an opportunity to speak will be limited to 5 minutes per person, with additional time allowed at the discretion of the chairperson.
Election of Officers
Approval of Minutes
- November 10, 2021 Open Session Minutes
Requests
- Request to waive 657 IAC 37.8 requiring the submission to the PMP a record of each reportable prescription dispensed during a reporting period – Dr. David Stilley, License 22603, Des Moines
- Request to waive 657 IAC 17.3(1)"c" requiring evidence of current drug distributor accreditation as a condition of licensure
- Jubilant HollisterStier LLC, Wholesale Distributor license 5465, Spokane, WA
- Request to waive 657 IAC 8.35(6)"c" requiring that a change in pharmacy ownership occurs when the majority ownership interest of the owner changes
- Bennett Pharmacy, Pharmacy license 770, New Hampton
Petition for Exemption from the Mandate for Electronic Transmission of Prescriptions
- Dr. Kenneth Hunziker, MD
Licensure/Registration Applications
- Demetria Simpson, PSP Applicant, Iowa City
- LeAnne Hicks, Technician Trainee Applicant, Ventura
- Request to grant the Executive Director authority to administratively approve registrations by consent agreement.
- Erica Evans, DPM, CSA Applicant, Clive
- Timothy G Gard, RPh, Pharmacist License Applicant, Liverpool, NY
- Randy Nicosko, RPh, Pharmacist License Applicant, Sioux Falls, SD
Reports & Informational Items
- Executive Director’s Report
- Meetings and Travel
- Legal Update
- Prescription Monitoring Program (PMP) Update
- Board-Sponsored Medication Disposal Update
- Iowa Monitoring Program for Pharmacy Professionals (IMP3) Update
- Compliance Report
- Proposed USP Revisions Update
- FDA Grants Emergency Use Authorization to Pzifer’s Paxlovid and Merck & Ridgeback’s Molnupiravir
Rules and Legislation
- Update on the 2022 Legislative Session/89th General Assembly
- IPA Legislative Priorities
- Proposed for adoption and filing to amend Chapter 39, "Expanded Practice Standards", to implement Senate File 296 relating to collaborative pharmacy practice agreements
- Proposed for Notice of Intended Action to amend Chapter 20, "Compounding Practices", to authorize the limited dispensing of an office stock compounded preparation by a veterinarian to the owner of an animal patient
- Proposed for Amended Notice of Intended Action to amend Chapter 6, "General Pharmacy Practice," Chapter 8, "Universal Practice Standards," and Chapter 10, "Controlled Substances," to provide minimum security and monitoring system requirements for Iowa pharmacies; require an exact measure or count of all controlled substances for a controlled substances inventory count; require a program be established to monitor controlled substance accountability; require a system be established to ensure controlled substance accountability; require development and execution of a corrective action plan following a theft or loss of controlled substances; and require a controlled substances inventory to be taken with each change in pharmacist in charge
- Statewide Protocols - Proposed for Amendment
- Influenza
- Strep
- Proposed Response or Comment to Proposed DEA Regulation
- Regulation of Telepharmacy Practice
- Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances Between Pharmacies for Initial Filling
Closed Session Agenda—these agenda items will be handled in closed session. For closed session agenda items requiring final action, the Board will vote on these items in open session.
Motion to go into closed session pursuant to Iowa Code section 21.5(1)(a), to review or discuss records which are required or authorized by state or federal law to be kept confidential; pursuant to Iowa Code section 21.5(1)(d), to discuss whether to initiate licensee disciplinary investigations or proceedings; and pursuant to Iowa Code section 21.5(1)(f), to discuss the decision to be rendered in a contested case conducted according to the provisions of Iowa Code chapter 17A.
- Review of Closed Session Minutes – 21.5(1)(a)
- November 10, 2021 Closed Session Minutes
- Complaints and Investigative Reports – 21.5(1)(d)
- Notice of Hearing and Statement of Charges – 21.5(1)(d)
- Combined Statement of Charges, Settlement Agreement and Final Orders – 21.5(1)(d) & (f)
Return to Open Session
Votes on any closed session agenda items requiring final action
Adjournment